Biotech entity
Every one of those 1 sits in a single category, fda-approval. Solius Labs is most often covered alongside Solius Pro, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Solius Labs appears in 1 tracked Biotech story from June 18, 2026.
Last mentioned: Jun 18, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, fda-approval. Solius Labs is most often covered alongside Solius Pro, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Solius Labs appears in 1 tracked Biotech story from June 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Solius Labs. Shared-story counts are live from our verified record — not editorial picks.
The FDA has established a novel product code for Solius Pro, an over-the-counter UVB light therapy device that claims to deliver biological benefits of sunlight with dramatically reduced risk. The move signals regulatory recognition of personalized home phototherapy as a distinct category.
Source: Business Wire (ca) · Business Wire (ca)
Solius Labs is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
